CoreWeave Reaffirms Strategic Rationale of its Proposed Acquisition and Financial Benefits to Core Scientific Stockholders

Core View - CoreWeave reaffirms its commitment to acquiring Core Scientific, emphasizing the financial benefits and strategic rationale for Core Scientific stockholders [1][2][6] Acquisition Details - CoreWeave entered into a definitive agreement to acquire Core Scientific in an all-stock transaction on July 7, 2025, which is positioned as the best path forward for Core Scientific stockholders, providing immediate premium value and long-term growth potential [2][4] - The acquisition is expected to create synergies through vertical integration, operational efficiencies, and expanded industry expertise, enhancing long-term value creation for shareholders [2][4] Response to Misleading Claims - CoreWeave addresses misleading statements made by Two Seas Capital regarding the acquisition, asserting that their offer is final and will not be modified [3][4] - The company argues that Core Scientific's standalone value-creation plan is riskier compared to the proposed acquisition, which mitigates significant execution risks and capital expenditure challenges [4][6] - CoreWeave highlights that its partnership has already led to a ~150% increase in Core Scientific's stock price over the 13 months prior to the acquisition announcement, compared to ~25% for peers [4][5] Market Position and Future Outlook - CoreWeave is confident that no alternative buyer can match its scale and ability to unlock value from Core Scientific's assets, reinforcing the strategic importance of the acquisition [5][9] - The upcoming Special Meeting on October 30, 2025, will allow stockholders to vote on the transaction, with CoreWeave urging them to support the merger proposal [7][8]